Drug Type Bispecific antibody |
Synonyms- |
Target |
Mechanism CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), FasR inhibitors(Apoptosis-mediating surface antigen FAS inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
B-Cell Malignant Neoplasm | Discovery | CH | 10 Aug 2022 |